Can you imagine people on here if we missed out on a decent slice of 6 BILLION?!?
Is Immunization/Vaccines part of the reason we where cash flow positive last quarter as well?
Strong cash flow generation in quarter driven by R&D refund of $1.5M relating to Admedus Vaccines and unwinding of working capital investments made in H1.
Just a thought.
Coads
Tissue Engineering v. Immunotherapy, page-18
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.380(2.07%) |
Mkt cap ! $348.5M | |||
| Open | High | Low | Value | Volume |
| $18.36 | $18.47 | $17.55 | $105.6K | 5.898K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 426 | $17.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.96 | 26 | 3 |
View Market Depth
| Last trade - 11.57am 03/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |